Ingram Condemns Anti-Abortion Legislation
Today, state Senator Catherine D. Ingram (D-Cincinnati) issued the following statement after Republicans in the Ohio Senate passed House Bill 347, which creates new burdensome restrictions for women seeking reproductive care, including a 24-hour waiting period, and House Bill 324, which restricts access to certain medications, including mifepristone, a safe and commonly used abortion medication.
“In 2023, Ohioans went to the ballot box and made their voices heard on this issue, yet this legislature continues to undermine the very people we were elected to represent,” said Ingram. “The sponsors’ rationale for these bills is insulting to Ohioans, suggesting they do not understand their own medical needs or the decisions they make. They do not need politicians involving themselves in these deeply personal decisions. Ohioans deserve the freedom to make their own healthcare choices, and these bills violate that freedom.”
H.B. 347 will require physicians to meet with a patient at least 24 hours before an elective abortion. The bill will also subject a physician to civil liability if they do not meet the consent requirements, or if they perform an abortion that broadly causes “harm” or death to any involved party.
H.B. 324 will limit access to safe and effective medications, like mifepristone, by creating burdensome and unnecessary requirements for patients and physicians by requiring in-person examinations and follow-up appointments for certain medications.
House Bills 347 and 324 now head to the governor for his signature.